CardiaTec
CardiaTec, a Cambridge-based firm developing an AI platform to discover drugs for cardiovascular diseases
Cambridge, UKwww.cardiatec.ai ↗
Total raised
€7.5M
€7,520,010
Funding rounds
2
Investors
11
distinct backers
Active since
2022-07
latest 2024-09
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood54
base rate 44% for Seed
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood12
base rate 12% (2+ rounds)
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-09-10 | Seed | €5.9M | APEX Ventures,Continuum Health Ventures,Dr. Maximilien Levesque ,Existing investors,Laidlaw Ventures ,Montage Ventures+1 more | View deal → |
| 2022-07-06 | Pre-Seed | €1.6M | APEX Ventures,Cambridge Enterprise,Crista Galli Ventures,Laidlaw Scholars Ventures (LSV),o2h Ventures | View deal → |
Investors
11Related news
- Cambridge’s CardiaTec gets €1.6M to tackle cardiovascular diseases using AI; here’s howsiliconcanals.com · 2022-07
- tech.eu